GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 19-002_006 Universitair Medisch Centrum Utrecht Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 15-09-2022 Vergunning verleend
IM-MV 20-001_004 UMCG Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy. 16-09-2022 Vergunning verleend
IM-MV 21-011_000 AMC AAV clinical vectors with a target nuclease as insert, used in vivo, to treat and/or prevent disease 12-09-2022 Vergunning verleend
IM-MV 21-014_003 LUMC Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy 16-09-2022 Vergunning verleend
IM-MV 21-015_003 Erasmus MC Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy 16-09-2022 Vergunning verleend